Steven Kuemmerle

Board Member at PROMISS Diagnostics

Steven Kuemmerle is the Special Adviser on Innovation and Industry Partnerships to the EVP of Research, Rosalind Franklin University of Medicine and Science, focused on establishing the new RFUMS Innovation and Research Park and Helix 51 Incubator, and developing industry-university collaborations. Steve has over three decades of healthcare industry experience. As Head of Venture Investments, Abbott Biotech Ventures, Inc., he led the evaluation and execution of equity investments in emerging pharma companies. Before that, Steve served as a director in Abbott’s Global Pharma Licensing Group. Steve first joined Abbott in 1987, where he managed various diagnostic R&D units before moving to the Pharmaceutical Division in 1997. Steve received his Ph.D. in Biochemistry from Northwestern University. He serves as an advisor and member on various healthcare non-profit and start-up company boards, and is Past-Chair of the Life Sciences Executive Committee for the Licensing Executive Society. Steve is a licensed airplane pilot, and enjoys hiking and sailing.

Timeline

  • Board Member

    Current role